"Designing Growth Strategies is in our DNA"

Stomach Cancer/Gastric Cancer Treatment Market Size, Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecast, 2019-2026

The global stomach cancer/gastric cancer treatment market size was USD 2.61 billion in 2018 and is projected to reach USD 8.20 billion by 2026, exhibiting a CAGR of 15.3%... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Feb, 2020 | Report ID: FBI102094 | Status : Published

 

Check Discount

Refresh Button
Stomach-Gastric- Cancer- Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2015-2017
  • 130
  • Choose License Type
  • 4850
    6850
    8850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X